Personal information

Countries

United Kingdom

Activities

Collapse all

Works (14)

Human-centred design of a new microneedle-based hormonal contraceptive delivery system [version 3; peer review: 1 approved, 2 approved with reservations]

2021-12-01 | Journal article
DOI: 10.12688/gatesopenres.13233.3
Part of ISSN: 2572-4754
Funded by GRANT_NUMBER: INV-010030, INV-009575
Contributors: Benedetta Gualeni; Louise Hughes; Isabelle Stauber; Louise Ackers; Angela Gorman; Dorothy Gashuga; Nettie Dzabala; Frider Chimimba; Ibrahim Chikowe; Sion A. Coulman et al.
Source: check_circle
Gates Open Research

Hollow silicon microneedle fabrication using advanced plasma etch technologies for applications in transdermal drug delivery.

Lab on a chip
2020-07-07 | Journal article
DOI: 10.1039/d0lc00567c
PMID: 32632424
Source: Self-asserted source
Benedetta Gualeni

Minimally invasive and targeted therapeutic cell delivery to the skin using microneedle devices.

The British journal of dermatology
2018-02-15 | Journal article
DOI: 10.1111/bjd.15923
PMID: 28865105
Source: Self-asserted source
Benedetta Gualeni

Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation.

Journal of cellular biochemistry
2014-10-01 | Journal article
DOI: 10.1002/jcb.24844
PMID: 24820054
PMC: PMC4262066
Source: Self-asserted source
Benedetta Gualeni

A novel transgenic mouse model of growth plate dysplasia reveals that decreased chondrocyte proliferation due to chronic ER stress is a key factor in reduced bone growth.

Disease models & mechanisms
2013-09-12 | Journal article
DOI: 10.1242/dmm.013342
PMID: 24046357
PMC: PMC3820264
Source: Self-asserted source
Benedetta Gualeni

Alteration of proteoglycan sulfation affects bone growth and remodeling.

Bone
2013-01-28 | Journal article
DOI: 10.1016/j.bone.2013.01.036
PMID: 23369989
PMC: PMC3607217
Source: Self-asserted source
Benedetta Gualeni

Matrix disruptions, growth, and degradation of cartilage with impaired sulfation.

The Journal of biological chemistry
2012-05-03 | Journal article
DOI: 10.1074/jbc.m110.116467
PMID: 22556422
PMC: PMC3381162
Source: Self-asserted source
Benedetta Gualeni

A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.

Human mutation
2011-11-17 | Journal article
DOI: 10.1002/humu.21631
PMID: 22006726
PMC: PMC3320758
Source: Self-asserted source
Benedetta Gualeni

Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling.

Matrix biology : journal of the International Society for Matrix Biology
2010-05-11 | Journal article
DOI: 10.1016/j.matbio.2010.05.001
PMID: 20470884
Source: Self-asserted source
Benedetta Gualeni

A quantitative and qualitative method for direct 2-DE analysis of murine cartilage.

Proteomics
2007-11-01 | Journal article
DOI: 10.1002/pmic.200700276
PMID: 17960732
Source: Self-asserted source
Benedetta Gualeni

Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta.

Proteomics
2007-06-01 | Journal article
DOI: 10.1002/pmic.200600919
PMID: 17520686
Source: Self-asserted source
Benedetta Gualeni

In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation.

The Biochemical journal
2006-09-01 | Journal article
DOI: 10.1042/bj20060566
PMID: 16719839
PMC: PMC1559448
Source: Self-asserted source
Benedetta Gualeni
grade
Preferred source (of 2)‎

Insights from a transgenic mouse model on the role of SLC26A2 in health and disease.

Novartis Foundation symposium
2006-01-01 | Journal article
PMID: 17120769
Source: Self-asserted source
Benedetta Gualeni

A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.

Human molecular genetics
2005-02-09 | Journal article
DOI: 10.1093/hmg/ddi079
PMID: 15703192
Source: Self-asserted source
Benedetta Gualeni
How many people are using ORCID?